Diabetes Management (Subscribe)
Press Releases
Acrongenomics Inc., Signs a US$ 6.5 Million (GBP 3.45 Million) Joint Development Agreement with Mole
Acrongenomics Inc. and Molecular Vision Ltd. entered into a joint collaboration in hopes of accelerating the development and commercialization of easy-to-use, low-cost and readily portable point-of-care (POC) diagnostic devices for personalized medical testing.